Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Rev. Soc. Bras. Clín. Méd ; 19(3): 176-180, set 2021.
Artículo en Portugués | LILACS | ID: biblio-1391950

RESUMEN

A busca pelo corpo perfeito pode gerar graves consequências para a população que faz uso indiscriminado de substâncias visando a resultados rápidos. O caso relatado se refere a um pa- ciente de 21 anos, do sexo masculino, na cidade de São Paulo (SP), que apresentou quadro de síndrome colestática 15 dias após uso do anabolizante estanazolol para fins estéticos na ativi- dade física, evoluindo com hepatite medicamentosa grave, com aumento de transaminases, hiperrubilinemia às custas de bilirrubina direta e fatores de coagulação, sem resposta satis- fatória ao tratamento de suporte convencional, com melhora significativa após introdução de corticoterapia.


Searching for the perfect body image can cause severe conse- quences to the population using substances indiscriminately to reach results fast. The case reported refers to a male patient, 21 years old, from the city of São Paulo (SP), who developed choles- tatic syndrome 15 days after the use of the steroid Stanazol for aesthetic purposes during physical activity, progressing with se- vere drug-induced hepatitis, transaminases, bilirubin, and coagu- lation factors increase with no satisfactory response to the con- ventional support treatment, and significant improvement after the introduction of corticotherapy.


Asunto(s)
Humanos , Masculino , Adulto , Adulto Joven , Estanozolol/toxicidad , Enfermedad Hepática Inducida por Sustancias y Drogas/tratamiento farmacológico , Glucocorticoides/uso terapéutico , Anabolizantes/toxicidad , Ácido Ursodesoxicólico/administración & dosificación , Bilirrubina/sangre , Biopsia , Colagogos y Coleréticos/uso terapéutico , Prednisona/administración & dosificación , Colestasis/diagnóstico , Colestasis/patología , Colesterol/sangre , Resina de Colestiramina/administración & dosificación , Enfermedad Catastrófica , Enfermedad Hepática Inducida por Sustancias y Drogas/diagnóstico , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Transaminasas/sangre , Hidroxizina/administración & dosificación , Hígado/patología , Anticolesterolemiantes/uso terapéutico , Antipruriginosos/uso terapéutico
2.
Rev. bras. enferm ; 72(3): 600-608, May.-Jun. 2019. tab, graf
Artículo en Inglés | BDENF, LILACS | ID: biblio-1013556

RESUMEN

ABSTRACT Objective: To evaluate the effectiveness of the menthol package (lip hydration and ice popsicles) compared to a package of non-menthol measures (lip hydration and ice popsicles) as a way to relieve thirst in patients in the Anesthetic Recovery Room. Method: Randomized and parallel trial study, with 120 patients randomized patients in an experimental group - menthol measurements (n=59) and control group - measures without menthol (n = 61). Results: There was a significant (p<0.05) decrease in intensity, hydration, dryness and taste in the oral cavity between the three moments of assessment/intervention in the two groups. The difference was significant in the experimental group for thirst intensity at the second assessment/intervention point (p<0.05) after a single administration of the menthol package. Conclusion: There was a reduction in thirst intensity in both groups. Patients who received menthol packages showed a significant decrease in intensity after a single evaluation/intervention time. NCT: 02869139.


RESUMEN Objetivo: Evaluar la efectividad del paquete de medidas mentoladas (hidratación labial y picolé de hielo) comparado a un paquete de medidas no mentoladas (hidratación labial y picolé de hielo) como un método de alivio de la sed en pacientes en la Sala de Recuperación Post-Anestésica. Método: En un ensayo clínico aleatorizado, paralelo, 120 pacientes aleatorizados en un grupo experimental - medidas mentoladas (n=59) y un grupo control - medidas sin el mentol (n=61). Resultados: Hubo una disminución significativa (p<0,05) sobre la intensidad, hidratación, sequedad y gusto en la cavidad oral entre los tres momentos de evaluación/intervención en los dos grupos, indistintamente. La diferencia fue significativa en el grupo experimental para la intensidad de la sed en el segundo momento de la evaluación/intervención (p<0,05) después de una única administración del paquete de medidas mentoladas. Conclusión: Se encontró una reducción de la intensidad de la sed en los dos grupos. Los pacientes que recibieron las medidas mentoladas presentaron una disminución significativa de la intensidad después de un único momento de evaluación/intervención. NCT: 02869139.


RESUMO Objetivo: Avaliar a efetividade do pacote de medidas mentoladas (hidratação labial e picolé de gelo) comparado a um pacote de medidas não mentoladas (hidratação labial e picolé de gelo) como método de alívio da sede em pacientes na Sala de Recuperação Anestésica. Método: Ensaio clínico randomizado, paralelo, 120 pacientes aleatorizados em grupo experimental - medidas mentoladas (n=59) e grupo controle - medidas sem o mentol (n=61). Resultados: Houve diminuição significativa (p<0,05) sobre a intensidade, hidratação, secura e gosto na cavidade oral entre os três momentos de avaliação/intervenção nos dois grupos indistintamente. A diferença foi significativa no grupo experimental para intensidade da sede no segundo momento de avaliação/intervenção (p<0,05) após uma única administração do pacote de medidas mentoladas. Conclusão: Houve redução da intensidade da sede nos dois grupos. Os pacientes que receberam as medidas mentoladas apresentaram diminuição significativa da intensidade após um único momento de avaliação/intervenção. A NCT: 02869139.


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Sed/efectos de los fármacos , Mentol/farmacología , Brasil , Modelos Lineales , Estadísticas no Paramétricas , Cirugía Bariátrica/efectos adversos , Cirugía Bariátrica/métodos , Mentol/uso terapéutico , Persona de Mediana Edad , Antipruriginosos/uso terapéutico , Antipruriginosos/farmacología , Obesidad/cirugía
3.
Rev. chil. infectol ; 35(4): 445-447, ago. 2018. graf
Artículo en Español | LILACS | ID: biblio-978056

RESUMEN

Resumen La infección por Strongyloides stercoralis es una parasitosis frecuente en las regiones tropicales y subtropicales, incluyendo la Amazonía peruana. En pacientes con inmunocompromiso, las manifestaciones clínicas son variadas y es frecuente la diseminación sistémica de la enfermedad, con compromiso de diversos órganos. Las manifestaciones cutáneas son infrecuentes y se describen en pacientes con algún grado de inmunosupresión. Se presenta el caso de un paciente inmunocompetente que desarrolló una púrpura reactiva por una infección por Strongyloides stercoralis crónica. Ante ello, es posible el compromiso cutáneo en pacientes inmunocompetentes con reagudización sistémica por este parásito.


Infection with Strongyloides stercoralis is a common parasitic infection in tropical and subtropical regions, including the Peruvian Amazon. The clinical manifestations are varied in patients with immunocompromised disease, and the systemic spread of the disease is frequent, compromising different organs and systems. Cutaneous manifestations are infrequent, being described in patients with some degree of immunosuppression. We present the case of an immunocompetent patient who developed a reactive purpura due to chronic Strongyloides stercoralis infection. Thus, skin involvement is possible in immunocompetent patients with systemic exacerbation due to this parasite.


Asunto(s)
Humanos , Animales , Masculino , Adulto , Adulto Joven , Púrpura/etiología , Púrpura/inmunología , Estrongiloidiasis/complicaciones , Estrongiloidiasis/inmunología , Púrpura/tratamiento farmacológico , Ivermectina/uso terapéutico , Clorfeniramina/uso terapéutico , Huésped Inmunocomprometido , Strongyloides stercoralis/aislamiento & purificación , Antiparasitarios/clasificación , Antiparasitarios/uso terapéutico , Antipruriginosos/uso terapéutico
4.
Rev. Soc. Bras. Clín. Méd ; 15(1): 61-67, 2017.
Artículo en Inglés | LILACS | ID: biblio-833180

RESUMEN

Pruritus represents one of the main clinical complaints in medical practice, and leads to significant impairment of life quality and some discomfort. Although the knowledge of its main primary and secondary etiologies is well-established in Internal Medicine, especially in Hepatology, its pathophysiological basis and specific therapeutic-directed approaches are still very complex and need a proper systematization for comprehension. This review aims to present the main current themes regarding the main clinical, pathophysiological, therapeutical and management aspects of cholestasis-associated pruritus. METHODS: The authors performed a wide review of practical clinical guidelines, review articles and original articles from manuscripts published and indexed in PubMed. CONCLUSIONS: Pruritus in cholestasis represents a complex symptom in clinical practice and can be secondary to different pathophysiological mechanisms; its early recognition allows a proper therapeutic approach in most cases.


O prurido representa uma das principais queixas clínicas na prática médica e origina importante comprometimento da qualidade de vida, além de desconforto. Apesar de suas principais etiologias primárias e secundárias serem de conhecimento bem estabelecido na Clínica Médica, em especial na Hepatologia, suas bases fisiopatológicas e os princípios da terapêutica específica direcionada são bastante complexos e necessitam uma sistematização adequada para sua compreensão apropriada. Esta revisão objetiva abordar os principais temas atuais referentes às bases clínicas, fisiopatológicas, terapêuticas e de manejo do prurido relacionados à colestase. Os autores realizaram ampla revisão em diretrizes clínicas práticas, artigos de revisão e publicações originais de artigos publicados e indexados na base PubMed. O prurido na colestase representa um sintoma complexo na prática clínica e pode decorrer de diferentes mecanismos fisiopatológicos secundários. Seu reconhecimento precoce possibilita a abordagem terapêutica apropriada na maioria dos casos.


Asunto(s)
Humanos , Antipruriginosos/uso terapéutico , Colestasis/complicaciones , Prurito/etiología , Prurito/terapia , Piel/inervación , Neuralgia/fisiopatología
5.
An. bras. dermatol ; 91(6): 791-798, Nov.-Dec. 2016. tab, graf
Artículo en Inglés | LILACS | ID: biblio-837980

RESUMEN

Abstract Among the wide range of symptoms neglected or resistant to conventional treatments in clinical practice, itch is emerging gradually as a theme to be studied. Itch complaints and the negative effects in the quality of life are observed in several medical fields. Although the partially obscure pathophysiology, some researchers decided to check and test the use of psychotropic drugs in resistant itch to conventional topical treatments and antihistamines. The objective of this study was to evaluate scientific evidence in psychotropic use in the treatment of itch of various causes. This is a systematic review of scientific literature. The following databases were used: PubMed, Web of Science, Scopus and Scielo. Randomized controlled trials that should focus on treatment with psychotropic drugs of pruritus of various causes were the inclusion criteria. All articles were analyzed by the authors, and the consensus was reached in cases of disagreement. Fifteen articles were included after analysis and selection in databases, with the majority of clinical trials focusing on psychopharmacological treatment of itch on account of chronic kidney disease. Clinical trials with psychotropic drugs mostly indicated significant improvement in the itching. In most trials of chronic kidney disease as basal disease for itch, greater effectiveness was observed with the use of psychotropic drugs compared with placebo or other antipruritic. However, the small amount of controlled trials conducted precludes the generalization that psychiatric drugs are effective for itch of various causes.


Asunto(s)
Humanos , Prurito/tratamiento farmacológico , Psicotrópicos/uso terapéutico , Prurito/etiología , Ensayos Clínicos Controlados Aleatorios como Asunto , Reproducibilidad de los Resultados , Resultado del Tratamiento , Ácidos Ciclohexanocarboxílicos/uso terapéutico , Doxepina/uso terapéutico , Ácido gamma-Aminobutírico/uso terapéutico , Aminas/uso terapéutico , Enfermedades Renales/complicaciones , Antipruriginosos/uso terapéutico
6.
An. bras. dermatol ; 89(4): 570-575, Jul-Aug/2014. tab, graf
Artículo en Inglés | LILACS | ID: lil-715546

RESUMEN

BACKGROUND: notalgia paresthetica is a subdiagnosed sensory neuropathy presenting as a condition of intense itching and hyperchromic macule on the back that interferes with daily habits. OBJECTIVES: To determine the efficacy of treatment of notalgia paresthetica using oral gabapentin, assessing the degree of improvement in itching and influence on quality of life. Moreover, to evaluate the signs and symptoms associated with notalgia paresthetica. METHODS: We conducted an experimental, non-randomized, parallel, non-blinded study including 20 patients with clinical and histopathological diagnosis of notalgia paresthetica. After application of the visual analogue scale of pain adapted for pruritus and of the questionnaire of dermatology life quality index (DLQI), ten patients with visual analogue scale > 5 were given treatment with gabapentin at the dose of 300 mg/day for four weeks. The other ten were treated with topical capsaicin 0.025% daily for four weeks. After the treatment period, patients answered again the scale of itching. RESULTS: The use of gabapentin was responsible for a significant improvement in pruritus (p=0.0020). Besides itching and hyperchromic stain on the back, patients reported paresthesia and back pain. It was observed that the main factor in the worsening of the rash is heat. CONCLUSION: Gabapentin is a good option for the treatment of severe itching caused by nostalgia paresthetica. .


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Aminas/uso terapéutico , Dolor de Espalda/tratamiento farmacológico , Ácidos Ciclohexanocarboxílicos/uso terapéutico , GABAérgicos/uso terapéutico , Parestesia/tratamiento farmacológico , Prurito/tratamiento farmacológico , Calidad de Vida , Ácido gamma-Aminobutírico/uso terapéutico , Antipruriginosos/uso terapéutico , Dolor de Espalda/patología , Capsaicina/uso terapéutico , Parestesia/patología , Prurito/patología , Encuestas y Cuestionarios , Resultado del Tratamiento , Escala Visual Analógica
7.
An. bras. dermatol ; 87(5): 735-741, Sept-Oct. 2012.
Artículo en Inglés | LILACS | ID: lil-651567

RESUMEN

Pruritus is a symptom that may be associated with a wide array of diseases - skin diseases, systemic diseases or even those without a defined cause. According to its severity and evolution, it may compromise the patients' quality of life in a significant way. New therapeutic approaches, in which histamine release is not the main event, are being described for pruritus control. Therefore, taking into account the origin of the mediators of pruritus, we conducted a review of the available resources emphasizing that, although very important, anti-histamines are not the answer for every kind of pruritus.


Prurido é um sintoma que pode estar associado a uma gama ampla de patologias, sejam elas cutâneas, sistêmicas ou mesmo sem causa definida . Conforme sua intensidade e evolução pode comprometer de forma significativa a qualidade de vida dos pacientes. Novas abordagens terapêuticas estão sendo descritas para o controle do prurido, onde a liberação da histamina não é o fator principal. Assim, baseando-se na origem de seus mediadores, faz-se uma revisão desses recursos e ressalta-se que, embora de grande importância no arsenal terapêutico, os anti-histamínicos não são a panacéia para todos os tipos de prurido.


Asunto(s)
Humanos , Antipruriginosos/uso terapéutico , Prurito/tratamiento farmacológico , Prurito/clasificación , Prurito/etiología , Prurito/metabolismo
8.
Indian J Biochem Biophys ; 2010 Apr; 47(2): 90-95
Artículo en Inglés | IMSEAR | ID: sea-135249

RESUMEN

The mast cell-mediated allergic reactions are involved in many allergic diseases, such as asthma, allergic rhinitis and sinusitis. Stimulation of mast cells initiates the process of degranulation, resulting in the release of mediators such as histamine and an array of inflammatory cytokines. In this report, we investigated the effect of gossypin (a biflavonoid) and suramin (a synthetic polysulphonated naphtylurea) on the mast cell-mediated allergy model, and studied the possible mechanism of their action. Both gossypin and suramin inhibited (P<0.001) compound 48/80-induced systemic anaphylaxis reactions, antiprurities (P<0.001) and reduced the histamine release in rats. Further, both showed significant (P<0.001) protection against rat peritoneal mast cells activated by compound 48/80. Thus, our findings provide evidence that gossypin and suramin inhibit mast cell-derived allergic reactions.


Asunto(s)
Anafilaxia/inducido químicamente , Anafilaxia/tratamiento farmacológico , Anafilaxia/inmunología , Animales , Antialérgicos/farmacología , Antialérgicos/uso terapéutico , Antipruriginosos/farmacología , Antipruriginosos/uso terapéutico , Líquido Ascítico/efectos de los fármacos , Líquido Ascítico/metabolismo , Líquido del Lavado Bronquioalveolar , Modelos Animales de Enfermedad , Flavonoides/farmacología , Flavonoides/uso terapéutico , Liberación de Histamina/efectos de los fármacos , Liberación de Histamina/inmunología , Hipersensibilidad/sangre , Hipersensibilidad/tratamiento farmacológico , Hipersensibilidad/inmunología , Hipersensibilidad/metabolismo , Mastocitos/efectos de los fármacos , Mastocitos/inmunología , Mastocitos/metabolismo , Ratones , Óxidos de Nitrógeno/sangre , Óxidos de Nitrógeno/metabolismo , Ratas , Suramina/farmacología , Suramina/uso terapéutico , p-Metoxi-N-metilfenetilamina/farmacología
9.
Rev. chil. dermatol ; 24(2): 128-131, 2008. tab
Artículo en Español | LILACS | ID: lil-567052

RESUMEN

El prurito es la causa más común de consulta en Dermatología. En el presente articulo se hace una revisión de los estudios más relevantes sobre el prurito y se revisan la fisiopatogenia y la relación con enfermedades de distinto tipo. Es importante recalcar la relación entre el prurito y la respuesta del SNC, en lo que se ha llamado la inflamación neurobiológica. Establecemos una forma racional de enfrentar el prurito tanto desde el punto de vista de laboratorio como de terapéutica.


Pruritus is the most common symptom in dermatology. We present a review of the most relevant studies of pruritus its physiopathology and relations with other types of diseases. It is important to emphasize the relation between pruritus the CNS in what is known as neurobiological. Additionally we. Additionally we propase a rational means of facing pruritus from both laboratory and therapeutic perspectives.


Asunto(s)
Humanos , Prurito/etiología , Prurito/fisiopatología , Prurito/terapia , Anestésicos Locales/uso terapéutico , Antipruriginosos/uso terapéutico , Enfermedades de la Piel/complicaciones , Enfermedades del Sistema Nervioso/complicaciones , Histamina/fisiología , Inflamación Neurogénica/fisiopatología , Neuropéptidos/fisiología , Fototerapia , Prurito/clasificación , Trastornos Mentales/complicaciones
10.
Rev. méd. Chile ; 130(12): 1407-1410, dic. 2002.
Artículo en Español | LILACS | ID: lil-356131

RESUMEN

Herbal medicine is a growing alternative for established medicine. Many plants and herbs are currently in use for a myriad of diseases and symptoms. However, there are many reports in the literature of life-threatening adverse effects of these drugs. We report a 39 years old male, that consulted for pain in the nostrils and severe nasal obstruction, that appeared two hours after instilling Ecballium elaterirum in the nostrils. On physical examination, uvular edema was observed. The patient was successfully managed with intravenous betametasone and chlorphenamine.


Asunto(s)
Humanos , Masculino , Adulto , Angioedema , Enfermedades de la Boca/inducido químicamente , Fitoterapia/efectos adversos , Úvula , Angioedema , Antiinflamatorios , Antipruriginosos/uso terapéutico , Automedicación , Betametasona/uso terapéutico , Clorfeniramina/uso terapéutico , Enfermedades de la Boca/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA